Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
2.920
+0.420 (16.80%)
At close: Jun 26, 2026, 4:00 PM EDT
2.870
-0.050 (-1.71%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$781,109
Market Cap
2.18M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Calidi Biotherapeutics | 29 |
| Silexion Therapeutics | 14 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| Oragenics | 3 |
BDRX News
- 10 days ago - Postponement and Re-scheduling of Annual General Meeting - GlobeNewsWire
- 6 weeks ago - Biodexa issues letter to Shareholders - GlobeNewsWire
- 3 months ago - Biodexa Pharmaceuticals PLC-ADR trading halted, news pending - TheFly
- 3 months ago - Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene - TheFly
- 3 months ago - Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies - GlobeNewsWire
- 3 months ago - Biodexa, Tanner Pharma launch global early access program for FAP patients - TheFly
- 3 months ago - Preliminary Results for the Year Ended 31 December 2025 - GlobeNewsWire
- 3 months ago - Biodexa Pharmaceuticals management to meet with Maxim - TheFly